Aspect Partners’s Eli Lilly LLY Stock Holding History

Aspect Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$116K	Sell	100 -1	-1%	-$1.18K	0.04%	107
2026 Q2	$121K	Hold	101	–	–	0.05%	102
2026 Q1	$92.9K	Hold	101	–	–	0.04%	108
2025 Q4	$109K	Buy	101 +7	+7%	+$6.69K	0.05%	102
2025 Q3	$71.7K	Sell	94 -251	-73%	-$187K	0.03%	130
2025 Q2	$269K	Buy	345 +250	+263%	+$194K	0.13%	69
2025 Q1	$78.5K	Hold	95	–	–	0.04%	111
2024 Q4	$73.3K	Sell	95 -4	-4%	-$3.31K	0.04%	111
2024 Q3	$87.7K	Hold	99	–	–	0.05%	98
2024 Q2	$89.6K	Hold	99	–	–	0.05%	93
2024 Q1	$77K	Hold	99	–	–	0.06%	100
2023 Q4	$57.7K	Buy	+99	New	+$57.8K	0.04%	108

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Old National Bancorp Evansville, Indiana $5.07B AUM 22.07% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Goelzer Investment Management Carmel, Indiana $2.28B AUM 31.27% 1-Year Est. Return

AMF Tjänstepension Stockholm, Sweden $17.2B AUM 28.3% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Aspect Partners's LLY Position: Q3 2026 in Review

Aspect Partners reduced its Eli Lilly (LLY) stake by 0.99% in Q3 2026, selling an estimated $1.18K and leaving 100 shares worth $116K. The position accounts for 0.04% of the portfolio, ranked #107.

Aspect Partners first reported a position in LLY in Q4 2023 and has held it in 12 quarters since. The position peaked at $269K in Q2 2025. 1,449 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Aspect Partners held 100 shares of Eli Lilly worth $116K as of Q3 2026.
Aspect Partners sold 1 Eli Lilly share in Q3 2026, an estimated $1.18K.
Eli Lilly made up 0.04% of Aspect Partners's portfolio in Q3 2026, its #107 holding.
Aspect Partners first reported a position in Eli Lilly in Q4 2023 and has held it in 12 quarters since.
Aspect Partners's Eli Lilly position peaked at $269K in Q2 2025.
1,449 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Aspect Partners's 13F filing for Q3 2026, filed 20 Oct 2026.